These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14636702)

  • 1. A predictive F344 rat immunotoxicology model: cellular parameters combined with humoral response to NP-CgammaG and KLH.
    Smith HW; Winstead CJ; Stank KK; Halstead BW; Wierda D
    Toxicology; 2003 Dec; 194(1-2):129-45. PubMed ID: 14636702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation.
    Gore ER; Gower J; Kurali E; Sui JL; Bynum J; Ennulat D; Herzyk DJ
    Toxicology; 2004 Apr; 197(1):23-35. PubMed ID: 15003331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of canine T-cell dependent antibody response to the primary and secondary immunization with keyhole limpet hemocyanin.
    Kawai R; Aida T; Hattori H; Furukawa T; Mori K; Takasaki W; Takahashi N; Kawada T
    J Toxicol Sci; 2013; 38(4):571-9. PubMed ID: 23824013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats.
    Kawai R; Ito S; Aida T; Hattori H; Kimura T; Furukawa T; Mori K; Sanbuissho A; Kawada T
    J Immunotoxicol; 2013; 10(1):40-8. PubMed ID: 22953734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of immune function testing during a 4-week oral toxicity study with FK506.
    Ulrich P; Paul G; Perentes E; Mahl A; Roman D
    Toxicol Lett; 2004 Apr; 149(1-3):123-31. PubMed ID: 15093257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune parameters are affected differently after cyclosporine A exposure in Fischer 344 rats and B6C3F1 mice: implications for immunotoxicology.
    Blot C; Lebrec H; Roger R; Bohuon R; Pallardy M
    Toxicology; 1994; 94(1-3):231-45. PubMed ID: 7801326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective roles of thymus-derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier-primed T cells on hapten-specific IgM and IgG antibody responses.
    Tada T; Takemori T
    J Exp Med; 1974 Jul; 140(1):239-52. PubMed ID: 4134784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of validation study of assessment of direct immunotoxicity in the rat. The ICICIS Group Investigators. International Collaborative Immunotoxicity Study.
    Toxicology; 1998 Feb; 125(2-3):183-201. PubMed ID: 9570332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response.
    Fleshner M; Deak T; Nguyen KT; Watkins LR; Maier SF
    J Immunol; 2001 Mar; 166(6):3813-9. PubMed ID: 11238624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of bis(tri-n-butyltin)oxide in the rat. II. Suppression of thymus-dependent immune responses and of parameters of nonspecific resistance after short-term exposure.
    Vos JG; de Klerk A; Krajnc EI; Kruizinga W; van Ommen B; Rozing J
    Toxicol Appl Pharmacol; 1984 Sep; 75(3):387-408. PubMed ID: 6474470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Candida albicans delayed-type hypersensitivity (DTH) model in the female B₆C₃F₁ mouse for use in immunotoxicological investigations.
    White KL; McLoughlin CE; Auttachoat W; Smith MJ
    J Immunotoxicol; 2012; 9(2):141-7. PubMed ID: 22339419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds.
    De Waal EJ; Timmerman HH; Dortant PM; Kranjc MA; Van Loveren H
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):327-38. PubMed ID: 7480886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice.
    Gadjeva M; Verschoor A; Brockman MA; Jezak H; Shen LM; Knipe DM; Carroll MC
    J Immunol; 2002 Nov; 169(10):5489-95. PubMed ID: 12421924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extension of the 4-week safety study for detecting immune system impairment appears not necessary: example of cyclosporin A in rats.
    Descotes G; Pinard D; Gallas JF; Penacchio E; Blot C; Moreau C
    Toxicology; 1996 Sep; 112(3):245-56. PubMed ID: 8845045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats.
    Vandebriel RJ; Tonk EC; de la Fonteyne-Blankestijn LJ; Gremmer ER; Verharen HW; van der Ven LT; van Loveren H; de Jong WH
    Part Fibre Toxicol; 2014 May; 11():21. PubMed ID: 24885556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated high dose oral exposure or continuous subcutaneous infusion of 2-methoxyacetic acid does not suppress humoral immunity in the mouse.
    Riddle MM; Williams WC; Smialowicz RJ
    Toxicology; 1996 May; 109(1):67-74. PubMed ID: 8619254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.
    Mise-Omata S; Sugiura T; Higashi K; Yamashita U
    Jpn J Cancer Res; 1999 Dec; 90(12):1277-84. PubMed ID: 10665643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
    Rentenaar RJ; van Diepen FN; Meijer RT; Surachno S; Wilmink JM; Schellekens PT; Pals ST; van Lier RA; ten Berge IJ
    Kidney Int; 2002 Jul; 62(1):319-28. PubMed ID: 12081594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.